Skip to main content

Table 6 Incremental cost-effectiveness calculations for the sensitivity analyses with the dominance report: “No strategies were clearly dominated by any other”

From: Cost-effectiveness of endovenous laser ablation of the great saphenous vein in patients with uncomplicated primary varicosis

Strategy Cost (€) Incremental cost (€) Effectiveness (QALY) Incremental effectiveness (QALY) Cost-efectiveness (€/QALY) Incremental cost-effectiveness (€/QALY)
Alternative 7       
 EVLT 2676.89   0.113   23626.54  
 HL/S 5756.33 3079.45 0.119 0.006 48291.39 521940.11
Alternative 8       
 EVLT 2676.89   0.360   7435.79  
 HL/S 5756.33 3079.45 0.367 0.007 15663.49 410592.89
Alternative 10       
 HL/S 924.67   0.161   5761.163  
 EVLT 1363.55 438.89 0.171 0.010 7978.66 42200.64
Alternative 11       
 HL/S 924.67   0.328   2819.97  
 EVLT 1363.55 438.89 0.351 0.023 3884.77 18999.42
Alternative 12       
 HL/S 3028.17   0.161   18867.08  
 EVLT 3332.13 303.97 0.171 0.010 19497.56 29227.56
Alternative 14       
 HL/S 3028.17   0.355   8530.05  
 EVLT 3332.13 303.97 0.380 0.025 8768.77 12158.67
Alternative 23       
 HL/S 924.67   −0.007   −127540.23  
 EVLT 1363.55 438.89 −0.003 0.004 −419554.87 109721.67
Alternative 25       
 HL/S 4971.33   −0.007   −685701.15  
 EVLT 7030.22 2058.89 −0.003 0.004 −2163144.62 514721.67